Global Acute Kidney Injury Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 27091

Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure.
In 2018, the global Acute Kidney Injury Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Kidney Injury Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Kidney Injury Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Quark Pharmaceuticals, Inc.
Baxter International, Inc.
Fresenius Medical Care AG & Co. KGaA
LG Chem
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Angion Biomedica Corp
...

Market segment by Type, the product can be split into
Prerenal Acute Kidney Injury
Postrenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Kidney Injury Treatment status, future forecast, growth opportunity, key market and key players.
To present the Acute Kidney Injury Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Kidney Injury Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Kidney Injury Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Prerenal Acute Kidney Injury
1.4.3 Postrenal Acute Kidney Injury
1.4.4 Intrinsic Renal Acute Kidney Injury
1.5 Market by Application
1.5.1 Global Acute Kidney Injury Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Kidney Injury Treatment Market Size
2.2 Acute Kidney Injury Treatment Growth Trends by Regions
2.2.1 Acute Kidney Injury Treatment Market Size by Regions (2019-2025)
2.2.2 Acute Kidney Injury Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Acute Kidney Injury Treatment Market Size by by Players
3.1.1 Global Acute Kidney Injury Treatment Revenue by by Players (2014-2019)
3.1.2 Global Acute Kidney Injury Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Acute Kidney Injury Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Acute Kidney Injury Treatment Key Players Head office and Area Served
3.3 Key Players Acute Kidney Injury Treatment Product/Solution/Service
3.4 Date of Enter into Acute Kidney Injury Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Kidney Injury Treatment Market Size by Type (2014-2019)
4.2 Global Acute Kidney Injury Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Acute Kidney Injury Treatment Market Size (2014-2019)
5.2 Acute Kidney Injury Treatment Key Players in North America
5.3 North America Acute Kidney Injury Treatment Market Size by Type
5.4 North America Acute Kidney Injury Treatment Market Size by Application

6 Europe
6.1 Europe Acute Kidney Injury Treatment Market Size (2014-2019)
6.2 Acute Kidney Injury Treatment Key Players in Europe
6.3 Europe Acute Kidney Injury Treatment Market Size by Type
6.4 Europe Acute Kidney Injury Treatment Market Size by Application

7 China
7.1 China Acute Kidney Injury Treatment Market Size (2014-2019)
7.2 Acute Kidney Injury Treatment Key Players in China
7.3 China Acute Kidney Injury Treatment Market Size by Type
7.4 China Acute Kidney Injury Treatment Market Size by Application

8 Japan
8.1 Japan Acute Kidney Injury Treatment Market Size (2014-2019)
8.2 Acute Kidney Injury Treatment Key Players in Japan
8.3 Japan Acute Kidney Injury Treatment Market Size by Type
8.4 Japan Acute Kidney Injury Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Kidney Injury Treatment Market Size (2014-2019)
9.2 Acute Kidney Injury Treatment Key Players in Southeast Asia
9.3 Southeast Asia Acute Kidney Injury Treatment Market Size by Type
9.4 Southeast Asia Acute Kidney Injury Treatment Market Size by Application

10 India
10.1 India Acute Kidney Injury Treatment Market Size (2014-2019)
10.2 Acute Kidney Injury Treatment Key Players in India
10.3 India Acute Kidney Injury Treatment Market Size by Type
10.4 India Acute Kidney Injury Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Acute Kidney Injury Treatment Market Size (2014-2019)
11.2 Acute Kidney Injury Treatment Key Players in Central & South America
11.3 Central & South America Acute Kidney Injury Treatment Market Size by Type
11.4 Central & South America Acute Kidney Injury Treatment Market Size by Application

12 International Players Profiles
12.1 Quark Pharmaceuticals, Inc.
12.1.1 Quark Pharmaceuticals, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Kidney Injury Treatment Introduction
12.1.4 Quark Pharmaceuticals, Inc. Revenue in Acute Kidney Injury Treatment Business (2014-2019))
12.1.5 Quark Pharmaceuticals, Inc. Recent Development
12.2 Baxter International, Inc.
12.2.1 Baxter International, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Kidney Injury Treatment Introduction
12.2.4 Baxter International, Inc. Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.2.5 Baxter International, Inc. Recent Development
12.3 Fresenius Medical Care AG & Co. KGaA
12.3.1 Fresenius Medical Care AG & Co. KGaA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Kidney Injury Treatment Introduction
12.3.4 Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.3.5 Fresenius Medical Care AG & Co. KGaA Recent Development
12.4 LG Chem
12.4.1 LG Chem Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Kidney Injury Treatment Introduction
12.4.4 LG Chem Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.4.5 LG Chem Recent Development
12.5 Asahi Kasei Medical Co., Ltd.
12.5.1 Asahi Kasei Medical Co., Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Kidney Injury Treatment Introduction
12.5.4 Asahi Kasei Medical Co., Ltd. Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.5.5 Asahi Kasei Medical Co., Ltd. Recent Development
12.6 B. Braun Melsungen AG
12.6.1 B. Braun Melsungen AG Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Kidney Injury Treatment Introduction
12.6.4 B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.6.5 B. Braun Melsungen AG Recent Development
12.7 Angion Biomedica Corp
12.7.1 Angion Biomedica Corp Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Kidney Injury Treatment Introduction
12.7.4 Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment Business (2014-2019)
12.7.5 Angion Biomedica Corp Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details